APA (7th ed.) Citation

G, B., D, C., G, C., CP, O., G, S., SM, L., . . . SR, S. (2025). The impact of swithching faricimab in the treatment of neovascular age-related macular degeneration: A real-world analysis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 263(11), 3097. https://doi.org/10.1007/s00417-025-06931-5

Chicago Style (17th ed.) Citation

G, Boscia, et al. "The Impact of Swithching Faricimab in the Treatment of Neovascular Age-related Macular Degeneration: A Real-world Analysis." Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie 263, no. 11 (2025): 3097. https://doi.org/10.1007/s00417-025-06931-5.

MLA (9th ed.) Citation

G, Boscia, et al. "The Impact of Swithching Faricimab in the Treatment of Neovascular Age-related Macular Degeneration: A Real-world Analysis." Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, vol. 263, no. 11, 2025, p. 3097, https://doi.org/10.1007/s00417-025-06931-5.